Financial Services
ChemoCentryx Inc(CCXI)
Live Price
Offline$10.22
-0.68% today
Window Change
-0.10%
Window
Feb 9, 2026 → Jun 16, 2026
- Market Cap
- $430.00M
- Revenue Growth
- 0.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 89 bars · Feb 9, 2026 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ChemoCentryx Inc (CCXI) is a Financial Services stock with a market cap of $430.00M and listed on NASDAQ. The stock last traded around $10.22 and down 0.1% across the available one-year price window (Feb 9, 2026 → Jun 16, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC -0.0%. Valuation already assumes a fairly strong business story at P/E 1492.7. Stock Foundry combines CCXI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +3.4% peer median
Operating Margin
Below sector median
0.0% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 0.0%.
Benchmark Edge
CCXI vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CCXI
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CCXI Max Drawdown
-1.66%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CCXI and SPY.
Company Overview
ChemoCentryx Inc
NASDAQ
Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
- Leadership
- Mr. Michael S. Klein
- Employees
- 178
- Street Address
- 640 Fifth Avenue, 14th Floor
- Mailing
- New York, NY, 10019
- Region
- New York, NY, United States
- Last Updated
- May 7, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 1492.7
- EV/EBITDA
- —
- Price/Sales
- —
- Price/Book
- 1.4
Growth
- Revenue
- 0.0%
- EPS
- 0.0%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 0.1%
- ROIC
- -0.0%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 8.13
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.